Sensus Healthcare (SRTS) Change in Receivables (2017 - 2026)
Sensus Healthcare's (SRTS) quarterly Change in Receivables came in at -$2.5 million in Q1 2026, down 43.78% year-on-year from -$4.4 million in Q1 2025, and up 25.25% quarter-over-quarter from -$3.3 million in Q4 2025.
Sensus Healthcare (SRTS) Change in Receivables (2017 - 2026) Analysis & Trends
Sensus Healthcare's Change in Receivables history runs 10 years deep, the most recent figure standing at -$2.5 million for Q1 2026.
- On a quarterly basis, Change in Receivables fell 43.78% year-over-year to -$2.5 million in Q1 2026; TTM through Mar 2026 was -$14.4 million, a 870.08% decrease from a year earlier, with the FY2025 full-year figure at -$13.6 million, down 248.18% from the prior year.
- Change in Receivables advanced to -$2.5 million in Q1 2026 per SRTS's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $10.0 million in Q4 2022 and bottomed at -$5.4 million in Q2 2025.
- The 5-year median for Change in Receivables is -$2.3 million (2023), against an average of -$484294.1.
- Biggest YoY gain for Change in Receivables was 667.86% in 2022; the steepest drop was 671.57% in 2022.
- Year by year, Change in Receivables stood at $10.0 million in 2022, then sank by 62.56% to $3.8 million in 2023, then decreased by 26.37% to $2.8 million in 2024, then tumbled by 218.95% to -$3.3 million in 2025, then grew by 25.25% to -$2.5 million in 2026.
- Per Business Quant, the three latest SRTS Change in Receivables figures stand at -$2.5 million (Q1 2026), -$3.3 million (Q4 2025), and -$3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | -2.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.46 Mn |
| Mar 31, 2026 | -2.46 Mn |
| Dec 31, 2025 | -3.30 Mn |
| Dec 31, 2025 | -3.30 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | -5.40 Mn |
| Jun 30, 2025 | -5.40 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Mar 31, 2025 | -1.71 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Jun 30, 2024 | -1.29 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Dec 31, 2023 | 3.76 Mn |